Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/9/2025

Combining Stimulants for ADHD Treatment

Introduction to Combination Therapy

  • The American Academy of Child and Adolescent Psychiatry recommends a maximum total daily amphetamine dose of 40mg, though clinical practice sometimes extends to 50mg 4

Critical Dosing Considerations

  • Adding Dexedrine 5mg BID to Vyvanse 50mg provides an additional 10mg of immediate-release dextroamphetamine daily, yielding a total daily amphetamine equivalent of approximately 60-65mg 1, 2, 3
  • Both Dexedrine 5mg doses must be completed before 2:00-3:00 PM to prevent insomnia 1, 2, 3, 4

Mandatory Monitoring Parameters

  • Blood pressure and heart rate should be monitored at every visit (quarterly minimum in adults) to detect hypertension or tachycardia 4, 5
  • Weight should be monitored at each visit to assess for appetite suppression and nutritional adequacy 4, 5
  • Sleep quality and duration should be monitored, as late-day dosing commonly causes insomnia 1, 2, 3
  • Mood changes, irritability, and anxiety should be monitored, which increase at higher amphetamine doses 4

Important Safety Caveats

  • Higher amphetamine doses increase the risk for hypertension and tachycardia 5
  • If maximum recommended doses fail to control symptoms adequately, increasing the dose further rarely provides additional benefit 5
  • Approximately 90% of patients respond when both amphetamine and methylphenidate classes are tried 6

Alternative Approach to Consider

  • The American Academy of Child and Adolescent Psychiatry suggests starting with dextroamphetamine 10-12.5mg total daily for patients on lisdexamfetamine 50mg requiring additional coverage 6

Common Pitfalls to Avoid

  • Do not give the afternoon Dexedrine dose after 2:00-3:00 PM, as this is the most common cause of treatment-related insomnia 1, 2, 3, 4
  • Do not continue escalating doses indefinitely if symptom control remains inadequate—this signals the need for a different therapeutic approach 4, 5

REFERENCES

1

Conversion Strategy for Adderall IR to XR + IR Combination [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Adderall XR Dosing Guidelines and Safety Considerations [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

Lisdexamfetamine to Dexamphetamine Conversion Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025